Under the action of SUMO-targeted ubiquitin ligase E3, PML is degraded through the proteasome pathway, leading to reduced levels of PML-RARα protein, which is followed by subsequent APL cell apoptosis (Geoffroy et al., 2010). The gene discussed is RARA; the disease is acute promyelocytic leukemia.